Do you provide alpha-MSH pathway regulation?
alpha-MSH signalling assays from receptor to melanin
alpha-MSH binds MC1R on the melanocyte surface and raises intracellular cAMP. That signal increases MITF, which in turn switches on tyrosinase and related pigment genes. An ingredient can act at several points on this route, and the study is designed to show where. The aim may be reduced or increased pigmentation, and the protocol is set accordingly.
Stimulated melanocyte design
Melanocytes are exposed to alpha-MSH to drive pigment production, and the test sample is added before or with the stimulus. Comparison groups include stimulated cells without the sample, unstimulated cells, vehicle controls and a pathway reference compound. Viability and cell number are recorded for each well. Timing matters, because cAMP rises within minutes of stimulation while melanin takes days to build up.
Points measured along the cascade
- Intracellular cAMP after stimulation
- MITF gene or protein expression
- Tyrosinase expression and cellular activity
- Melanin content normalised to cell number
- Concentration-response and time-course data
Placing the effect in the pathway
Reading upstream and downstream markers together lets the laboratory tell pathway modulation apart from a direct effect on the enzyme. When receptor binding itself is the claim, a dedicated binding assay is added. A cell-free tyrosinase activity assay can run in parallel to check for direct enzyme effects. The report sets out each marker against controls, with a short interpretation of the most likely point of action.
Using alpha-MSH pathway data in development and claims
Commission this work when your ingredient claim names a signalling mechanism, for example an active that dampens hormone-driven melanin production or one that supports the tanning response. The data adds depth to a supplier dossier and helps formulators compare actives that share a mechanism.
Point of action and receptor binding needs to state
Describe the proposed point of action, the pigment direction you expect, and the concentrations you plan to test. Share any earlier enzyme or melanin results, since they help the laboratory choose which markers to include. Say if you need receptor binding data, because it uses a separate assay format with labelled ligand.
Picking a signalling laboratory
Choose a provider with experience in stimulated melanocyte models and with cAMP and gene expression methods in-house. Ask to see an example report that shows stimulated and unstimulated controls side by side. A laboratory that can follow up with MITF expression studies keeps the whole pathway under one protocol.
More in Pigmentation & Melanogenesis
Pigmentation & Melanogenesis testing studies how actives change melanin synthesis, melanocyte behaviour and pigment transfer in lab models.











